Editorial team
ioQuanta Research Desk
-
Evidence date ·What a new crystal design leaves out about manufacturing and performance
PreprintA July 2026 preprint separates structural novelty from useful properties and performance in use, outlining what evidence each kind of materials claim needs.
-
Evidence date ·What combined leukemia studies found about antibody treatment
Review or Meta-AnalysisFor acute lymphoblastic leukemia, a 14-study review found better survival and remission odds with antibody treatment than with chemotherapy alone.
-
Evidence date ·What could an immune-modulating drug add to myeloma antibody treatment?
Peer-Reviewed PaperA 2021 paper explains how antibodies enlist natural killer cells and macrophages against myeloma, and why immune-modulating drugs might reinforce that response.
-
Evidence date ·Why training immune cells may not be enough against childhood cancer
Review or Meta-AnalysisEarly cancer vaccine studies in children reported immune responses but few clinical responses. Target selection and tumor suppression may help explain the gap.
-
Evidence date ·Immune-marker results can differ between an original tumor and its metastasis
Review or Meta-AnalysisA review estimated that PD-L1 test results differed in about one in five primary tumor–metastasis pairs, raising questions about relying on the original biopsy alone.
-
Evidence date ·What a 19-study analysis found about added immune-cell treatment for advanced liver cancer
Review or Meta-AnalysisAcross 19 studies, added immune-cell treatment was linked to more complete tumor responses and lower rates of death or progression during follow-up.
-
Evidence date ·What can a melanoma-looking spot reveal after immunotherapy?
Review or Meta-AnalysisIn 10 patients, biopsies of melanoma-like lesions found pigment-filled cells but no living melanoma cells in the sample; some patients still had progression.
-
Evidence date ·How do breast cancer risk genes relate to treatment when tumors vary?
Review or Meta-AnalysisA 2021 survey covers BRCA1’s roles in cell division and DNA-damage response, and why tumor diversity complicates breast cancer treatment research.
-
Evidence date ·What the mulberry review found about movement, memory and stroke
Review or Meta-AnalysisA 47-study review reported better Parkinson-like movement with fruit extracts and greater drug-induced immobility with a leaf extract in separate animal experiments.
-
Evidence date ·Looking at T-cell proteins to understand dysfunction inside tumors
Review or Meta-AnalysisA 2021 review explores how mass spectrometry could measure many proteins at once to study T-cell dysfunction inside tumors.